| Pathway | Enrichment Score | NES | P value | FDR adjusted p value | Q values |
---|---|---|---|---|---|---|
HELQ expression associated pathways | Kras signaling | − 0.435668418 | − 2.1532 | 1.00E−10 | 5.00E−09 | 3.05E−09 |
Hedgehog signaling | − 0.42542167 | − 1.6012 | 0.00905 | 0.0266321 | 0.01626 | |
coagulation | − 0.40041732 | − 1.9035 | 1.78E−06 | 1.78E−05 | 1.09E−05 | |
Myogenesis | − 0.366088795 | − 1.8159 | 3.62E−06 | 2.64E−05 | 1.61E−05 | |
Epithelial mesenchymal transition | − 0.365397776 | − 1.8159 | 3.69E−06 | 2.64E−05 | 1.61E−05 | |
Bile acid metabolism | − 0.340839788 | − 1.5737 | 0.00346 | 0.0123508 | 0.00754 | |
Estrogen response late | − 0.335392317 | − 1.6646 | 7.44E−05 | 0.0004131 | 0.00025 | |
Inflammatory response | − 0.332882791 | − 1.6521 | 0.0001 | 0.000507 | 0.00031 | |
Spermatogenesis | − 0.312304664 | − 1.4807 | 0.00614 | 0.0191922 | 0.01172 | |
Estrogen response early | − 0.307378963 | − 1.5247 | 0.00124 | 0.0051754 | 0.00316 | |
Xenobiotic metabolism | − 0.304376309 | − 1.5098 | 0.00158 | 0.0060767 | 0.00371 | |
DNA repair | 0.240957608 | 1.47711 | 0.00535 | 0.0178322 | 0.01089 | |
MYC targets | 0.255275512 | 1.66642 | 7.34E−05 | 0.0004131 | 0.00025 | |
G2M checkpoint | 0.301740945 | 1.98069 | 1.82E−07 | 2.28E−06 | 1.39E−06 | |
E2F targets | 0.304239585 | 1.99709 | 1.16E−07 | 1.93E−06 | 1.18E−06 | |
Mitotic spindle | 0.30860828 | 1.97486 | 4.61E−08 | 1.15E−06 | 7.04E−07 | |
Protein secretion | 0.32775742 | 1.88719 | 0.00013 | 0.0005808 | 0.00035 | |
EGR3 expression associated pathways | Interferon alpha response | − 0.498828541 | − 2.3019 | 7.24E−09 | 3.62E−07 | 1.45E−07 |
Cholesterol homeostasis | − 0.433630867 | − 1.8937 | 8.29E−05 | 0.0003453 | 0.00014 | |
Reactive oxigen species pathway | − 0.410797211 | − 1.6669 | 0.00434 | 0.0120436 | 0.00482 | |
Coagulation | − 0.381436147 | − 1.8811 | 8.40E−06 | 5.59E−05 | 2.24E−05 | |
Myogenesis | − 0.35817246 | − 1.8869 | 3.24E−06 | 3.24E−05 | 1.30E−05 | |
Interferon gamma response | − 0.353929759 | − 1.8643 | 1.82E−06 | 2.27E−05 | 9.09E−06 | |
IL6-JAK-STAT3 signaling | − 0.345542037 | − 1.5649 | 0.00978 | 0.0232876 | 0.00932 | |
Kras signaling | − 0.329603523 | − 1.732 | 8.04E−05 | 0.0003453 | 0.00014 | |
epithelial mesenchymal transition | − 0.32757194 | − 1.7247 | 4.34E−05 | 0.0002168 | 8.67E−05 | |
Estrogen response late | − 0.321965048 | − 1.6931 | 0.00013 | 0.0004868 | 0.00019 | |
Inflammatory response | − 0.306318547 | − 1.6109 | 0.00055 | 0.0019486 | 0.00078 | |
Complement | − 0.286012557 | − 1.5067 | 0.00293 | 0.0086057 | 0.00344 | |
Apoptosis | − 0.278729142 | − 1.4182 | 0.01129 | 0.0243914 | 0.00976 | |
Estrogen response early | − 0.272180964 | − 1.4339 | 0.00861 | 0.0215358 | 0.00861 | |
Glycolysis | − 0.268495638 | − 1.4144 | 0.01088 | 0.0243914 | 0.00976 | |
Adipogenesis | − 0.26708006 | − 1.4058 | 0.00807 | 0.0212352 | 0.00849 | |
Hypoxia | − 0.264798339 | − 1.3925 | 0.01171 | 0.0243914 | 0.00976 | |
Allograft rejection | − 0.260668803 | − 1.3732 | 0.01705 | 0.0340906 | 0.01364 | |
PI3K-Akt-mTOR signaling | 0.312772587 | 1.4756 | 0.01953 | 0.0375598 | 0.01502 | |
DNA repair | 0.326826349 | 1.62277 | 0.00084 | 0.0027889 | 0.00112 | |
Mitotic spindle | 0.339594124 | 1.78072 | 3.16E−05 | 0.0001753 | 7.01E−05 | |
G2M checkpoint | 0.357870462 | 1.86809 | 4.20E−06 | 3.50E−05 | 1.40E−05 | |
E2F targets | 0.399460879 | 2.08519 | 2.71E−08 | 4.51E−07 | 1.80E−07 | |
MYC targets v1 | 0.401746954 | 2.09159 | 1.97E−08 | 4.51E−07 | 1.80E−07 | |
MYC targets v2 | 0.428081704 | 1.80452 | 0.00173 | 0.0054071 | 0.00216 | |
Protein secretion | 0.440075051 | 2.06176 | 8.94E−06 | 5.59E−05 | 2.24E−05 |